Literature DB >> 16107613

RhoC is dispensable for embryogenesis and tumor initiation but essential for metastasis.

Anne Hakem1, Otto Sanchez-Sweatman, Annick You-Ten, Gordon Duncan, Andrew Wakeham, Rama Khokha, Tak W Mak.   

Abstract

The Rho proteins are Ras-related guanosine triphosphatases (GTPases) that function in cytoskeletal reorganization, cell migration, and stress fiber and focal adhesion formation. Overexpression of RhoC enhances the ability of melanoma cells to exit the blood and colonize the lungs. However, in vivo confirmation of RhoC's role in metastasis has awaited a RhoC-deficient mouse model. Here we report the generation of RhoC-deficient mice and show that RhoC is dispensable for embryonic and post-natal development. We demonstrate that loss of RhoC does not affect tumor development but decreases tumor cell motility and metastatic cell survival leading to a drastic inhibition of metastasis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16107613      PMCID: PMC1199568          DOI: 10.1101/gad.1310805

Source DB:  PubMed          Journal:  Genes Dev        ISSN: 0890-9369            Impact factor:   11.361


  20 in total

1.  A role for small GTPase RhoA in regulating intracellular membrane traffic of lysosomes in invasive rat hepatoma cells.

Authors:  Yukio Nishimura; Kazuyuki Itoh; Kiyoko Yoshioka; Kazuhiko Ikeda; Masaru Himeno
Journal:  Histochem J       Date:  2002-05

Review 2.  Rho GTPases in cell biology.

Authors:  Sandrine Etienne-Manneville; Alan Hall
Journal:  Nature       Date:  2002-12-12       Impact factor: 49.962

Review 3.  Cell migration: Rho GTPases lead the way.

Authors:  Myrto Raftopoulou; Alan Hall
Journal:  Dev Biol       Date:  2004-01-01       Impact factor: 3.582

Review 4.  Guanine nucleotide exchange factors for Rho GTPases: turning on the switch.

Authors:  Anja Schmidt; Alan Hall
Journal:  Genes Dev       Date:  2002-07-01       Impact factor: 11.361

5.  Apoptosis induced by Rac GTPase correlates with induction of FasL and ceramides production.

Authors:  N Embade; P F Valerón; S Aznar; E López-Collazo; J C Lacal
Journal:  Mol Biol Cell       Date:  2000-12       Impact factor: 4.138

6.  Expression of CD31 by cells of extensive ductal in situ and invasive carcinomas of the breast.

Authors:  A Sapino; M Bongiovanni; P Cassoni; L Righi; R Arisio; S Deaglio; F Malavasi
Journal:  J Pathol       Date:  2001-06       Impact factor: 7.996

7.  Genomic analysis of metastasis reveals an essential role for RhoC.

Authors:  E A Clark; T R Golub; E S Lander; R O Hynes
Journal:  Nature       Date:  2000-08-03       Impact factor: 49.962

8.  RhoB is dispensable for mouse development, but it modifies susceptibility to tumor formation as well as cell adhesion and growth factor signaling in transformed cells.

Authors:  A X Liu; N Rane; J P Liu; G C Prendergast
Journal:  Mol Cell Biol       Date:  2001-10       Impact factor: 4.272

9.  Induction of mammary tumors by expression of polyomavirus middle T oncogene: a transgenic mouse model for metastatic disease.

Authors:  C T Guy; R D Cardiff; W J Muller
Journal:  Mol Cell Biol       Date:  1992-03       Impact factor: 4.272

10.  Analysis of thymocyte development reveals that the GTPase RhoA is a positive regulator of T cell receptor responses in vivo.

Authors:  I Corre; M Gomez; S Vielkind; D A Cantrell
Journal:  J Exp Med       Date:  2001-10-01       Impact factor: 14.307

View more
  143 in total

1.  The anaphase-promoting complex/cyclosome activator Cdh1 modulates Rho GTPase by targeting p190 RhoGAP for degradation.

Authors:  Hideaki Naoe; Kimi Araki; Osamu Nagano; Yusuke Kobayashi; Jo Ishizawa; Tatsuyuki Chiyoda; Takatsune Shimizu; Ken-ichi Yamamura; Yutaka Sasaki; Hideyuki Saya; Shinji Kuninaka
Journal:  Mol Cell Biol       Date:  2010-06-07       Impact factor: 4.272

2.  Smg1 is required for embryogenesis and regulates diverse genes via alternative splicing coupled to nonsense-mediated mRNA decay.

Authors:  David R McIlwain; Qun Pan; Patrick T Reilly; Andrew J Elia; Susan McCracken; Andrew C Wakeham; Annick Itie-Youten; Benjamin J Blencowe; Tak W Mak
Journal:  Proc Natl Acad Sci U S A       Date:  2010-06-21       Impact factor: 11.205

3.  Androgen-Regulated SPARCL1 in the Tumor Microenvironment Inhibits Metastatic Progression.

Authors:  Paula J Hurley; Robert M Hughes; Brian W Simons; Jessie Huang; Rebecca M Miller; Brian Shinder; Michael C Haffner; David Esopi; Yasunori Kimura; Javaneh Jabbari; Ashley E Ross; Nicholas Erho; Ismael A Vergara; Sheila F Faraj; Elai Davicioni; George J Netto; Srinivasan Yegnasubramanian; Steven S An; Edward M Schaeffer
Journal:  Cancer Res       Date:  2015-08-20       Impact factor: 12.701

Review 4.  Metastasis suppressor proteins: discovery, molecular mechanisms, and clinical application.

Authors:  Carrie W Rinker-Schaeffer; James P O'Keefe; Danny R Welch; Dan Theodorescu
Journal:  Clin Cancer Res       Date:  2006-07-01       Impact factor: 12.531

5.  Evolution of the Rho family of ras-like GTPases in eukaryotes.

Authors:  Anthony Boureux; Emmanuel Vignal; Sandrine Faure; Philippe Fort
Journal:  Mol Biol Evol       Date:  2006-10-11       Impact factor: 16.240

Review 6.  Therapeutic intervention based on protein prenylation and associated modifications.

Authors:  Michael H Gelb; Lucas Brunsveld; Christine A Hrycyna; Susan Michaelis; Fuyuhiko Tamanoi; Wesley C Van Voorhis; Herbert Waldmann
Journal:  Nat Chem Biol       Date:  2006-10       Impact factor: 15.040

Review 7.  GTP-binding proteins of the Rho/Rac family: regulation, effectors and functions in vivo.

Authors:  Xosé R Bustelo; Vincent Sauzeau; Inmaculada M Berenjeno
Journal:  Bioessays       Date:  2007-04       Impact factor: 4.345

Review 8.  Targeting the mevalonate cascade as a new therapeutic approach in heart disease, cancer and pulmonary disease.

Authors:  Behzad Yeganeh; Emilia Wiechec; Sudharsana R Ande; Pawan Sharma; Adel Rezaei Moghadam; Martin Post; Darren H Freed; Mohammad Hashemi; Shahla Shojaei; Amir A Zeki; Saeid Ghavami
Journal:  Pharmacol Ther       Date:  2014-02-26       Impact factor: 12.310

9.  A Phase I Study of GGTI-2418 (Geranylgeranyl Transferase I Inhibitor) in Patients with Advanced Solid Tumors.

Authors:  Thomas B Karasic; E Gabriela Chiorean; Said M Sebti; Peter J O'Dwyer
Journal:  Target Oncol       Date:  2019-10       Impact factor: 4.493

10.  Diverse roles for the paxillin family of proteins in cancer.

Authors:  Nicholas O Deakin; Jeanine Pignatelli; Christopher E Turner
Journal:  Genes Cancer       Date:  2012-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.